KBC Securities

KBC Securities is a major Belgian investment bank and a subsidiary of KBC Group NV. It advises companies about their strategic development and provides funding to facilitate it. It specializes in drawing up tailored solutions in a range of domains to among others:

Public companies that are looking to raise fresh capital. They can count on KBC Securities' considerable capacity to place shares and bonds. KBC Securities is the market reference in Belgian equity capital market transactions. KBC Securities also supports public companies through the provision of specialized services that are designed to enhance liquidity, visibility and strategic business operations.

Institutional investors that want to access European and US markets. They can turn to a highly motivated team of research analysts and sales who adopt a meticulous approach to their work and have an eye for detail.

Companies and their shareholders that are looking at M&A (buy-and sell-side) as a strategic option. For our M&A business, we are part of Oaklins, the number 1 mid-market M&A advisor globally, active in more than 45 countries through 70 offices.

One of the key focus areas of KBC Securities is life sciences and it is our ambition to continue to be the trusted advisor for our life sciences companies. We want to help our clients to fully develop the potential of their innovations by providing them with the capital they need to bring it to the patient, by connecting them to the right investors. KBC Securities has a 20 year legacy in the field, having been involved in almost all life sciences transactions on Euronext Brussels, and raising almost €2bn for the sector to date.